Movano Health Secures Vital Extension for Nasdaq Listing Compliance Efforts

Movano Health, which operates under the ticker symbol MOVE on the Nasdaq, has recently announced a significant development regarding its stock market listing status. The company received a letter from the Nasdaq Hearings Panel on August 27, 2025, granting Movano Health an extension to remain listed on the exchange. This extension comes with the requirement that the company complies with specific listing rules crucial for maintaining its presence on Nasdaq.

Compliance Requirements

The Nasdaq listing requirements include a crucial regulation, Listing Rule 5250(c)(1), which mandates timely filing of periodic reports. To continue its listing, Movano Health must file its overdue Quarterly Reports on Form 10-Q for the quarters ending March 31, 2025, and June 30, 2025, by the deadline of September 30, 2025. Furthermore, the company must demonstrate compliance with the Bid Price Rule, as per Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, by October 30, 2025.

The extension followed a hearing on August 19, 2025, during which the panel reviewed the company’s compliance strategy. Movano Health is working closely with a newly appointed auditor to finalize and submit the necessary documents to the Securities and Exchange Commission (SEC).

Shareholder Involvement

In addition to addressing its reporting obligations, Movano Health has initiated a Preliminary Proxy Statement for its upcoming Annual Shareholders Meeting scheduled for September 26, 2025. This meeting will give shareholders an opportunity to approve a proposed reverse stock split. This strategic move could potentially help the company meet the Bid Price Rule effectively within the extension period.

About Movano Health

Founded in 2018, Movano Health is dedicated to creating innovative healthcare solutions that integrate medical-grade data into wearable devices. One of their flagship products, the Evie Ring, exemplifies their commitment to providing users with actionable health insights through advanced technology and design.

This company supports a vision where wearables generate comprehensive health data, empowering individuals to monitor their health proactively. By advancing their product suite, Movano Health aims to cater to different patient populations and improve health outcomes by making real-time data available to both consumers and healthcare providers.

Looking Ahead

As Movano Health takes these essential steps to restore its compliance with Nasdaq regulations, the future looks promising. The company is positioned to leverage its technology and dedication to health monitoring, ultimately enhancing the daily lives of its consumers.

However, success in this endeavor hinges on meeting the deadlines set by the panel and achieving shareholder consensus on the proposed reverse stock split. Such strategic actions are not just about compliance; they are integral to Movano Health's vision of transforming the health and wellness landscape through technology.

In conclusion, while challenges lie ahead, Movano Health's proactive approach in addressing these listing requirements signals a strong commitment to its operational and strategic goals. Stakeholders will be closely watching to see whether the company can rise to the occasion, ensuring its place in the competitive landscape of health technology.